Paulo L. Junior

Ribeirao Preto, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Relative strength of major determinants of quality of life in rheumatoid arthritis: an observational, cross-sectional study in tertiary rheumatology centres.

Relative strength of major determinants of quality of life in rheumatoid arthritis: an observational, cross-sectional study in tertiary rheumatology centres.

Journal: BMJ open
Published: July 24, 2026

Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study.

Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study.

Journal: Advances in rheumatology (London, England)
Published: August 08, 2022

Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study.

Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study.

Journal: Advances in rheumatology (London, England)
Published: May 20, 2022

The Behaviour of Serum Survivin in Patients With Lupus Nephritis.

The Behaviour of Serum Survivin in Patients With Lupus Nephritis.

Journal: Biomarker insights
Published: March 27, 2022

Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study.

Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study.

Journal: Advances in rheumatology (London, England)
Published: February 19, 2021

Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.

Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.

Journal: PloS one
Published: September 18, 2019

High Levels of Polypharmacy in Rheumatoid Arthritis-A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study.

High Levels of Polypharmacy in Rheumatoid Arthritis-A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study.

Journal: Journal of pharmacy practice
Published: August 28, 2019

Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study.

Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study.

Journal: Advances in rheumatology (London, England)
Published: July 10, 2019

Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.

Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.

Journal: PloS one
Published: April 05, 2019

Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis.

Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis.

Journal: International journal of clinical pharmacy
Published: February 21, 2019

Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.

Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.

Journal: PloS one
Published: November 14, 2018

The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil.

The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil.

Journal: Advances in rheumatology (London, England)
Published: March 05, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026